We are live on ! Find out more

Tema Neuroscience and Mental Health ETF

MNTL

Market cap $10.5M

Delisted

MNTL was delisted on the 6th of August, 2025.

Back to rankings

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 0%

Negative 0%

Tema Announces Liquidation of Two ETFs

NEW YORK--(BUSINESS WIRE)--After careful consideration, Tema ETFs LLC, investment adviser to Tema Luxury ETF and the Tema Neuroscience and Mental Health ETF (the "Funds"), has recommended, and the Board of Trustees of Tema ETF Trust has approved, the termination and liquidation of the Funds. Accordingly, the Funds are expected to cease operations and liquidate on or about August 1, 2025 (the "Liquidation Date").

Tema Announces Liquidation of Two ETFs

Hone Your Biotech Allocation in Neuroscience ETF MNTL

Tech investing poses one of the more important, and more fascinating, questions before investors entering 2025. Tech firms contributed outsized returns for the whole market, but do they pose concentration risks?

Hone Your Biotech Allocation in Neuroscience ETF MNTL

MNTL ETF: Neuroscience & Mental Health ETF

Tema ETFs recently launched the neuroscience and mental health ETF. MNTL ETF is designed to invest in companies at the forefront of combating neurological diseases and psychiatric disorders.

This Week in ETFs: Closures Outnumber New ETFs

Although 14 new ETFs debuted in the U.S. this past week, closure announcements came in even stronger, largely due to Global X pruning its lineup. Launches during the week included funds from BondBloxx, WisdomTree, Innovator, JPMorgan, and Range ETFs.

See News Rankings

Price charts implemented using Lightweight Charts™